
The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …

As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …

The Association of the British Pharmaceutical Industry has launched a new guide to explain how pharma and the NHS can …
The UK pharma industry’s Code of Practice is set to be updated to bring it into line with changes in …

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …
The ABPI has set up a new group to help pharma with its online communications. The UK industry body said …

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …

The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct. The complaint was …
A survey of pharma’s research partnerships and funding of UK academics has raised concerns about the future of British science.The …
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …

Boehringer Ingelheim has breached the ABPI’s Code of Conduct over the use of its Pradaxa website. Pradaxa is a …

The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …